Here are Monday’s top Wall Street analyst calls:
Oppenheimer maintained its outperform rating on Netflix, citing the platform's capability to attract substantial live-event viewership, as demonstrated by the Jake Paul-Mike Tyson fight.
"While the headlines may spotlight technical glitches and customer complaints, we believe viewership likely doubled internal expectations—a high-quality issue that Netflix can address by Christmas."
Citi began coverage of AI and cloud infrastructure firm Astera Labs with a bullish outlook, assigning a buy rating and a $120 target price.
Goldman Sachs initiated coverage of IT solutions provider Ingram Micro and railcar company Gatx, rating both as buys. The firm set a $33 price target for Ingram Micro and a $185 target for Gatx, highlighting their strong positioning in their respective sectors.
RBC expressed confidence in TechnipFMC’s ability to convert its $14.7 billion backlog into profits and shareholder returns. The firm sees this as a foundation for the company’s robust medium-term outlook.
UBS started coverage of Franco-Nevada and Wheaton Precious Metals with buy ratings, emphasizing their lower-risk profiles and reliable exposure to gold price growth and organic expansion.
HSBC upgraded Moderna from hold to buy, stating that the biotech firm’s pipeline offers a promising return to growth and is currently undervalued.
Baird upgraded Roku to outperform from neutral, citing a compelling long-term investment opportunity. "Roku has dropped 25% year-to-date compared to the S&P 500's 23% gain. While execution has been a concern, we now believe the market is underestimating positive shifts in Roku’s business."
Morgan Stanley raised its rating on Asia-based brokerage firm Futu to overweight from equal weight, citing its overseas expansion as a driver for long-term growth. The firm described the recent stock correction as an attractive entry point.
UBS upgraded Air Products and Chemicals to buy, anticipating a rerating for the stock. The firm increased its fiscal year 2025/26 adjusted EPS estimates, now surpassing consensus by 1% and 5%, respectively.
Raymond James boosted its rating on Hewlett Packard Enterprise to strong buy from outperform. The firm highlighted the company’s AI platform and server growth, which led to upward revisions of fiscal 2025 sales projections.
Goldman Sachs downgraded online real estate platform Redfin to sell from neutral, citing rising competition and assigning a $6.50 12-month price target.
Wells Fargo upgraded CVS to overweight from equal weight, raising its price target to $66. The firm believes challenges tied to Aetna’s aggressive growth strategies have peaked, creating an attractive investment opportunity.
Needham downgraded Biogen from buy to hold, citing limited upside potential for the stock over the next year.
Bank of America reiterated buy ratings for Nvidia and Alphabet. For Nvidia, the firm remains optimistic ahead of its earnings report this week, forecasting higher-than-consensus revenue. For Alphabet, the firm highlighted positive trends in Google’s search business and AI-driven advancements, setting the stage for an eventful 2025.
BMO upgraded Bright Horizons Family Solutions to outperform, citing potential for margin expansion despite recent slowing in top-line growth.
Loop upgraded Monolithic Power Systems to buy from hold, suggesting investors take advantage of the stock’s recent dip while maintaining a $660 price target.
Needham upgraded Robinhood to buy, attributing the move to potential regulatory changes under Donald Trump’s administration that could benefit the company.
Bernstein maintained its underperform rating on Tesla, despite the stock’s 28% surge following Trump’s election. The firm expressed concerns about potential policy changes under the new administration, such as reduced tax credits and relaxed emissions standards, which could negatively affect the EV industry.
As a leading independent research provider, TradeAlgo keeps you connected from anywhere.